FDG PET/CT findings in recurrent malignant schwannoma.

Abstract

Malignant schwannoma is an uncommon but aggressive sarcoma that most commonly arises in young and middle-aged adults. We present a 28-year-old male patient with a recurrent chest wall malignant schwannoma. An FDG PET/CT was performed to evaluate the management of the patient. The PET/CT images showed hypermetabolic mass lesions in the left upper chest wall and increased FDG uptake in the left axillary region. The pathologic results confirmed the PET findings. We conclude that FDG PET/CT could play an important role in the staging, restaging, and post-therapy follow-up of malignant schwannomas.

• Authors: Metin Halac, Ferahnaz Cnaral, Sager Sait, Selda Ylmaz, Sönmezoglu Kerim, Dervisoglu Sergülen, Ilhami Uslu
• Journal: Clinical nuclear medicine (Clin Nucl Med) Vol. 33 Issue 3 Pg. 172-4 (Mar 2008) ISSN: 0363-9762 [Print] United States
• PMID: 18287838 (Publication Type: Case Reports, Journal Article)

Chemical References

• Radiopharmaceuticals
• Fluorodeoxyglucose F18

Topics

• Adult
• Axilla (diagnostic imaging)
• Fluorodeoxyglucose F18
• Humans
• Male
• Muscle Neoplasms (diagnostic imaging)
• Neoplasm Recurrence, Local (diagnostic imaging)
• Neurilemmoma (diagnostic imaging)
• Positron-Emission Tomography
• Radiography
• Radiopharmaceuticals
• Thoracic Wall (diagnostic imaging)
• Tomography, Emission-Computed